Oncopeptides Completes Patient Enrollment in Phase 2 PORT Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to Oncopeptides Completes Patient Enrollment in Phase 2 PORT Study
Oncology Med, Inc. (NASDAQ: ONCO) Delayed: 1.02 -0.07 (6.42%)
Previous Close $1.09    52 Week High $0.00 
Open $1.08    52 Week Low $0.00 
Day High $1.11    P/E N/A 
Day Low $0.95    EPS $0.00 
Volume 399,152       

Oncology Med, Inc. (NASDAQ: ONCO) Delayed: 1.02 -0.07 (6.42%)
Previous Close $1.09    52 Week High $0.00 
Open $1.08    52 Week Low $0.00 
Day High $1.11    P/E N/A 
Day Low $0.95    EPS $0.00 
Volume 399,152       

Oncology Med, Inc. (NASDAQ: ONCO) Delayed: 1.02 -0.07 (6.42%)
Previous Close $1.09    52 Week High $0.00 
Open $1.08    52 Week Low $0.00 
Day High $1.11    P/E N/A 
Day Low $0.95    EPS $0.00 
Volume 399,152